Log in

NASDAQ:BCRXBioCryst Pharmaceuticals SEC Filings & 10K Form

$3.97
-0.03 (-0.75 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.81
Now: $3.97
$4.03
50-Day Range
$3.89
MA: $4.67
$5.44
52-Week Range
$1.38
Now: $3.97
$6.29
Volume6.45 million shs
Average Volume6.51 million shs
Market Capitalization$700.31 million
P/E RatioN/A
Dividend YieldN/A
Beta2.76

SEC Filings

BioCryst Pharmaceuticals (NASDAQ:BCRX) SEC Filings

DateFilerForm TypeView
08/06/2020
6:25 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
6:14 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2020
4:07 PM
BioCryst Pharmaceuticals (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SC 13G
06/10/2020
3:32 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2020
3:32 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2020
3:31 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/01/2020
7:30 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
5:07 AM
BioCryst Pharmaceuticals (Filer)
Form 424B2
05/27/2020
4:16 PM
BioCryst Pharmaceuticals (Filer)
Form 424B5
05/15/2020
3:20 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
11:15 PM
BioCryst Pharmaceuticals (Filer)
Form EFFECT
05/14/2020
3:36 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
3:21 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
3:18 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:15 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
7:55 AM
BioCryst Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2020
4:30 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioCryst Pharmaceuticals (Subject)
Form SC 13G
04/09/2020
7:11 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
9:51 AM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2020
6:55 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
11:53 AM
BioCryst Pharmaceuticals (Filer)
Form DEFA14A
03/31/2020
11:52 AM
BioCryst Pharmaceuticals (Filer)
Form DEF 14A
03/30/2020
6:20 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2020
3:15 PM
BioCryst Pharmaceuticals (Filer)
Form PRE 14A
03/13/2020
2:36 PM
BioCryst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2020
8:26 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
6:24 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
6:24 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
3:49 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
3:42 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:13 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:11 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:57 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:53 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:20 PM
BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
02/14/2020
3:14 PM
BAKER BROS. ADVISORS LP (Filed by)
BioCryst Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2020
12:17 PM
BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/03/2020
6:21 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2020
4:01 PM
BioCryst Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
01/21/2020
7:59 AM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/17/2020
8:05 AM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/15/2020
6:15 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
5:32 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
4:13 PM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 4/A
12/26/2019
4:09 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4/A
12/19/2019
4:55 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
4:52 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
4:49 PM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
4:47 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
4:36 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
4:34 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:28 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
4:17 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
4:14 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
4:12 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
4:09 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
12:16 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
8:06 AM
BioCryst Pharmaceuticals (Filer)
Form 424B5
11/20/2019
6:59 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
3:42 PM
BioCryst Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
11/18/2019
3:17 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:16 PM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:14 PM
BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:10 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:08 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:05 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:03 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:01 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
8:36 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
4:25 PM
BioCryst Pharmaceuticals (Filer)
Form 424B2
11/08/2019
3:45 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2019
8:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
6:31 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
6:02 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
6:32 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
6:37 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
6:20 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
3:27 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
3:25 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/23/2019
8:45 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
7:38 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
3:16 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
3:14 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
3:12 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
3:08 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:08 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:45 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
12:25 PM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
8:21 AM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
7:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
6:41 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
3:29 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
3:02 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/04/2019
2:00 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:23 PM
BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:21 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:19 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:16 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.